“…In the presented study, blood flow was measured using DCE-MRI with administration of a BPCA (0.25 mmol ml −1 gadofosveset trisodium; Vasovist, Bayer Schering, Berlin, Germany/Ablavar, Lantheus Medical Imaging, Inc., USA). The BPCA was administered at a dose of 0.1 ml kg −1 body weight and an injection rate of 5 ml s −1 , followed by 20 ml 0.9% saline solution at the same injection rate (for more details see Hindel et al 2018). In healthy microvessels, the BPCA gadofosveset trisodium is retained intravascularly within the first minute of intravenous injection.…”